公司資料
LeMaitre Vascular 股價、新聞與催化劑
- 股票代碼:
- LMAT
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
82.51 USD (+0.16%)
收盤價
最後更新: 2026年8月17日
2.09B USD
市值
股價為何變動
As of Aug 17, 2026, LMAT was little changed and closed at $82.51. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products. The business is rooted in procedure-linked vascular care.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, LeMaitre sits in niche medtech.
商業模式特徵
Revenue comes from surgeon adoption, recurring product use, and steady growth in vascular procedures.
生技產業定位
LeMaitre is a disciplined medtech name that trades on procedural demand and product execution rather than biotech catalysts.
未來催化劑
- LeMaitre's catalysts are vascular-graft demand, biologic patch adoption, and product-cycle execution in specialty surgery. The stock improves when recurring demand stays steady.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。